OncoMatch/Clinical Trials/NCT07757490
Sonablate HIFU International Registry for PC & BPH Patients
Is NCT07757490 recruiting? Yes, currently enrolling (Sep 2026). Studying High Intensity Focused Ultrasound for localized prostate cancer.
Treatment: High Intensity Focused Ultrasound — The SONA FUSION Registry is an observational study designed to evaluate the long-term effectiveness and safety of the Sonablate High-Intensity Focused Ultrasound (HIFU) system. This study focuses on adult men who have been treated for localized prostate cancer, benign prostatic hyperplasia (BPH) with urinary symptoms, or a combination of both conditions. The registry collects real-world medical data from multiple clinics globally to better understand how well the HIFU treatment controls disease and affects urinary and sexual function over a 10- to 20-year period. The study includes two groups of participants: a retrospective group of patients who previously received treatment, and a prospective group of newly treated patients receiving standard clinical care. No experimental interventions are assigned for the purpose of this study. To protect participant privacy, all medical data is completely de-identified and stripped of direct identifiers before being securely transferred to the central coordinating center at Indiana University. The ultimate goal of this research is to improve patient care protocols, advance men's health knowledge, and establish evidence-based guidelines for minimally invasive prostate treatments.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Prostate Cancer
Disease stage
Required: Stage LOCALIZED
Excluded: Stage IV
localized prostate cancer
Demographics
Prior therapy
Must have received: Sonablate HIFU ablation
Having undergone Sonablate HIFU ablation as part of standard clinical care
Cannot have received: radical prostatectomy
Prior radical prostatectomy
Cannot have received: rectal wall surgery
Prior rectal wall surgery
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Indiana University Medical Center · Indianapolis, Indiana
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07757490 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radical prostatectomy, rectal wall surgery disqualifies patients from enrollment.
What disease stage is eligible?
Stage LOCALIZED is required.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages